InvestorsHub Logo
Followers 208
Posts 32048
Boards Moderated 1
Alias Born 06/30/2009

Re: frenchbroad post# 392094

Sunday, 08/07/2022 9:04:00 PM

Sunday, August 07, 2022 9:04:00 PM

Post# of 402178
"Did you see this news also on Friday?
https://www.mdpi.com/2079-6382/11/8/1062/htm";

That paper may have been published on Friday but as far as B is concerned it can hardly be called news. In fact it continues to laud the preclinical work that was done prior to the Covid trial without making any reference at all to the results of the trial itself.

It's a shame that you think that for them to say that "it has been proven to have antiviral activity, inhibiting the SARS-CoV-2 virus in Vero African green monkey kidney cells and Calu-3 human lung epithelial cells, and showing a synergistic inhibitory activity in combination with the antiviral remdesivir " without also mentioning that in a clinical trial "Brilacidin did not show a difference compared to placebo in reducing Time to Sustained Recovery Through Day 29, the study’s primary endpoint based on clinical status" is newsworthy. It's not...it's deceptive to those who do not know better.

It's morally wrong to allow a sucker to keep his money.
......W. C. Fields

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News